Henri Azaïs

Dr. Henri Azaïs

1. AP-HP (Assistance Publique des Hôpitaux de Paris), Department of Gynaecological Oncological and Breast Surgery, Hôpital Européen Georges-Pompidou, 75015 Paris, France
+2

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AGAmirah Mohd Gazzali
Amirah Mohd Gazzali
MLMathilde Lobry
Mathilde Lobry
LCLudovic Colombeau
Ludovic Colombeau
Samir AcherarSamir Acherar
Samir Acherar
HAHenri Azaïs
Henri Azaïs
Céline FrochotCéline Frochot
Céline Frochot

19 October 2023 in Journal of Robotic Surgery
Verified
Journal Article
Open access
PDF file
LLLouis Lenfant
Louis Lenfant
GCGeoffroy Canlorbe
Geoffroy Canlorbe
JBJérémie Belghiti
Jérémie Belghiti
UKUsha Seshadri Kreaden
Usha Seshadri Kreaden
AHApril E. Hebert
April E. Hebert
HAHenri Azaïs
Henri Azaïs
The potential benefits and limitations of benign hysterectomy surgical approaches are still debated. We aimed at evaluating any differences with a systematic review and meta-analysis. PubMed, MEDLINE, and EMBASE databases were last searched on 6/2/2021 to identify English randomized controlled trials (RCTs), prospective cohort and retrospective independent database studies published between Jan 1, 2010 and Dec 31, 2020 reporting perioperative outcomes following robotic hysterectomy versus laparoscopic, open, or vaginal approach (PROSPERO #CRD42022352718). Twenty-four articles were included that reported on 110,306 robotic, 262,715 laparoscopic, 189,237 vaginal, and 554,407 open patients. The robotic approach was associated with a shorter hospital stay (p < 0.00001), less blood loss (p = 0.009), and fewer complications (OR: 0.42 [0.27, 0.66], p = 0.0001) when compared to the open approach. The main benefit compared to the laparoscopic and vaginal approaches was a shorter hospital (R/L WMD: – 0.144 [– 0.21, – 0.08], p < 0.0001; R/V WMD: – 0.39 [– 0.70, – 0.08], p = 0.01). Other benefits seen were sensitive to the inclusion of database studies. Study type differences in outcomes, a lack of RCTs for robotic vs. open comparisons, learning curve issues, and limited robotic vs. vaginal publications are limitations. While the robotic approach was mainly comparable to the laparoscopic approach, this meta-analysis confirms the classic benefits of minimally invasive surgery when comparing robotic hysterectomy to open surgery. We also reported the advantages of robotic surgery over vaginal surgery in a patient population with a higher incidence of large uterus and prior surgery.

16 June 2019 in Cancers
Verified
Journal Article
Open access
PDF file
RDRomain Delangle
Romain Delangle
TFTiphaine de Foucher
Tiphaine de Foucher
ALAnnette K. Larsen
Annette K. Larsen
Michèle SABBAHMichèle SABBAH
Michèle SABBAH
HAHenri Azaïs
Henri Azaïs
GCGeoffroy Canlorbe
Geoffroy Canlorbe
Introduction: Endometrial cancer (EC) is the most important gynecological cancer in terms of incidence. microRNAs (miRs), which are post-transcriptional regulators implicated in a variety of cellular functions including carcinogenesis, are particularly attractive candidates as biomarkers. Indeed, several studies have shown that the miR expression pattern appears to be associated with prognostic factors in EC. Our objective is to review the current knowledge of the role of miRs in carcinogenesis and tumor progression and their association with the prognosis of endometrial cancer. Materials and Method: We performed a literature search for miR expression in EC using MEDLINE, PubMed (the Internet portal of the National Library of Medicine) and The Cochrane Library, Cochrane databases “Cochrane Reviews” and “Clinical Trials” using the following keywords: microRNA, endometrial cancer, prognosis, diagnosis, lymph node, survival, plasma, FFPE (formalin-fixed, paraffin-embedded). The miRs were classified and presented according to their expression levels in cancer tissue in relation to different prognostic factors. Results: Data were collected from 74 original articles and 8 literature reviews which described the expression levels of 261 miRs in ECs, including 133 onco-miRs, 110 miR onco-suppressors, and 18 miRs with discordant functions. The review identified 30 articles studying the expression pattern of miR in neoplastic endometrial tissue compared to benign and/or hyperplastic tissues, 12 articles detailing the expression profile of miRs as a function of lymph node status, and 14 articles that detailed the expression pattern of miRs in endometrial tumor tissue according to overall survival or in the absence of recurrence. Conclusions: The findings presented here suggest that miR analysis merits a role as a prognostic factor in the management of patients with endometrial cancer.

1 March 2016 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
HAHenri Azaïs
Henri Azaïs
CSCaroline SCHMITT
Caroline SCHMITT
MTMeryem Tardivel
Meryem Tardivel
OKOlivier Kerdraon
Olivier Kerdraon
ASAurélie Stallivieri
Aurélie Stallivieri
Serge MordonSerge Mordon
Serge Mordon

1 January 2021 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
NBnicolas bourdel
nicolas bourdel
CHC. Huchon
C. Huchon
CWC. Abdel Wahab
C. Abdel Wahab
HAHenri Azaïs
Henri Azaïs
SBS. Bendifallah
S. Bendifallah
EDE. Daraï
E. Daraï

1 March 2017 in Surgical Oncology
Verified
Journal Article
Closed access
HAHenri Azaïs
Henri Azaïs
JEJuan Pablo Estevez
Juan Pablo Estevez
PFPérine Foucher
Périne Foucher
YKYohan Kerbage
Yohan Kerbage
Serge MordonSerge Mordon
Serge Mordon
PCPierre Collinet
Pierre Collinet